[1]
Abdul Malik, “Beyond Glycaemic Control: The Expanding Role of GLP-1 Receptor Agonists in Obesity, Obstructive Sleep Apnoea, Cardiovascular Disease, and Steatohepatitis: A Narrative Review”, JHWCR, vol. 4, no. 11, pp. 1–12, Jun. 2026, doi: 10.61919/7n09x564.